explore
Previous article:
Medical leaders decry Supreme Court decision on affirmative action
Next article: The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies
Next article: The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies
focus
leisure time
-
Study on Amgen’s bispecific immunotherapy produces positive data
2025-08-12 08:12 -
Susan Tousi leaves Illumina to head cancer liquid biopsy startup
2025-08-12 08:11 -
3 medical device trends to watch in 2024
2025-08-12 07:29 -
Why psychiatrists like me stop taking insurance
2025-08-12 07:28 -
Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal
2025-08-12 06:55 -
STAT Readout Newsletter: Biotech news today
2025-08-12 06:31